These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21084265)

  • 21. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barré syndrome after H1N1 influenza: a concern.
    Wiwanitkit V
    Neuroepidemiology; 2013; 40(4):295. PubMed ID: 23485791
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.
    Simpson BS; Rajabally YA
    Eur J Neurol; 2009 Apr; 16(4):e81. PubMed ID: 19222546
    [No Abstract]   [Full Text] [Related]  

  • 26. Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?
    Nelson KE
    Am J Epidemiol; 2012 Jun; 175(11):1129-32. PubMed ID: 22582208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza vaccine and Guillain-Barré syndrome: making informed decisions.
    Poland GA; Poland CM; Howe CL
    Lancet; 2013 Apr; 381(9876):1437-9. PubMed ID: 23622271
    [No Abstract]   [Full Text] [Related]  

  • 28. Pandemic (H1N1) 2009 influenza.
    Polkinghorne B; Ward K; Totaro R
    N S W Public Health Bull; 2010; 21(1-2):41-2. PubMed ID: 21367344
    [No Abstract]   [Full Text] [Related]  

  • 29. The Guillain-Barré syndrome: a true case of molecular mimicry.
    Ang CW; Jacobs BC; Laman JD
    Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?
    Price LC
    BMJ; 2009 Sep; 339():b3577. PubMed ID: 19740925
    [No Abstract]   [Full Text] [Related]  

  • 31. Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events.
    Jones TF; McMillian M; Boothe E; Hanna S; Ingram LA
    Emerg Infect Dis; 2010 Sep; 16(9):1500-1. PubMed ID: 20735949
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute transverse myelitis and acute motor axonal neuropathy developed after vaccinations against seasonal and 2009 A/H1N1 influenza.
    Sato N; Watanabe K; Ohta K; Tanaka H
    Intern Med; 2011; 50(5):503-7. PubMed ID: 21372468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
    Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
    Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome after exposure to influenza virus.
    Lehmann HC; Hartung HP; Kieseier BC; Hughes RA
    Lancet Infect Dis; 2010 Sep; 10(9):643-51. PubMed ID: 20797646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
    Choe YJ; Cho H; Bae GR; Lee JK
    Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandemic influenza: a priority for the neurological community.
    Lancet Neurol; 2009 Oct; 8(10):869. PubMed ID: 19747645
    [No Abstract]   [Full Text] [Related]  

  • 37. Guillain-Barré syndrome and influenza vaccines: current evidence.
    Sanz Fadrique R; Martín Arias L; Molina-Guarneros JA; Jimeno Bulnes N; García Ortega P
    Rev Esp Quimioter; 2019 Aug; 32(4):288-295. PubMed ID: 31232571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.
    van Sorge NM; van der Pol WL; Jansen MD; van den Berg LH
    Autoimmun Rev; 2004 Feb; 3(2):61-8. PubMed ID: 15003189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurologic adverse events following influenza A (H1N1) vaccinations in children.
    Lee SJ; Kim YO; Woo YJ; Kim MK; Nam TS; Cho YK
    Pediatr Int; 2012 Jun; 54(3):325-30. PubMed ID: 22299607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient.
    Tremblay ME; Closon A; D'Anjou G; Bussières JF
    Ann Pharmacother; 2010; 44(7-8):1330-3. PubMed ID: 20484170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.